Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PPFIBP2-BRAF fusion
i
Other names:
PPFIBP2, PPFIA Binding Protein 2, Protein Tyrosine Phosphatase Receptor Type F Polypeptide-Interacting Protein-Binding Protein 2, PTPRF Interacting Protein, Binding Protein 2 (Liprin Beta 2), Liprin-Beta-2, Liprin Beta 2, PTPRF-Interacting Protein-Binding Protein 2, Cclp1, BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/t
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
673
;
8495
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
KIAA1549-BRAF fusion (10)
BRAF fusion (9)
AGK-BRAF fusion (5)
SKAP2-BRAF fusion (4)
TARDBP-BRAF fusion (4)
FKBP15-BRAF fusion (3)
CUL1-BRAF fusion (2)
SLC45A3-BRAF fusion (2)
SND1-BRAF fusion (2)
BRAF-MAD1L1 fusion (1)
BRAF-ZC3H7A fusion (1)
CUX1-BRAF fusion (1)
EXOC4-BRAF fusion (1)
NRF1-BRAF fusion (1)
TRIM33-BRAF fusion (1)
ZKSCAN1-BRAF fusion (1)
KIAA1549-BRAF fusion (10)
BRAF fusion (9)
AGK-BRAF fusion (5)
SKAP2-BRAF fusion (4)
TARDBP-BRAF fusion (4)
FKBP15-BRAF fusion (3)
CUL1-BRAF fusion (2)
SLC45A3-BRAF fusion (2)
SND1-BRAF fusion (2)
BRAF-MAD1L1 fusion (1)
BRAF-ZC3H7A fusion (1)
CUX1-BRAF fusion (1)
EXOC4-BRAF fusion (1)
NRF1-BRAF fusion (1)
TRIM33-BRAF fusion (1)
ZKSCAN1-BRAF fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PPFIBP2-BRAF fusion
Melanoma
PPFIBP2-BRAF fusion
Melanoma
trametinib
Sensitive: C4 – Case Studies
trametinib
Sensitive
:
C4
trametinib
Sensitive: C4 – Case Studies
trametinib
Sensitive
:
C4
PPFIBP2-BRAF fusion
Melanoma
PPFIBP2-BRAF fusion
Melanoma
fotemustine
Sensitive: C4 – Case Studies
fotemustine
Sensitive
:
C4
fotemustine
Sensitive: C4 – Case Studies
fotemustine
Sensitive
:
C4
PPFIBP2-BRAF fusion
Melanoma
PPFIBP2-BRAF fusion
Melanoma
ipilimumab
Sensitive: C4 – Case Studies
ipilimumab
Sensitive
:
C4
ipilimumab
Sensitive: C4 – Case Studies
ipilimumab
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.